Quantitative Immunoassay Life Science Dashboard Dublin,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
74
Quantitative Immunoassay Life Science Dashboard

Dublin, April 17, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Quantitative Immunoassay Life Science Dashboard Series 3" report to their offering. Immunoassays are commonly used laboratory tests for identification and quantification of proteins. With a range of applications in diagnosis of cancer, immunology and disease research, immunoassays are widely used by scientists in academia and industry. The 2016 Quantitative Immunoassay Dashboard is the third in a series that characterizes the dynamic market for immunoassay products. This 2016 Dashboard provides a snapshot of the current market landscape that is compared with data from all of the previous Quantitative Immunoassay Dashboards , and was developed from responses to a 48-question survey completed by 592 scientists located in North America and Europe.

This Dashboard reveals key market indicators for the Quantitative Immunoassay market as a whole as well as for the following techniques representing market sub-segments: - Colorimetric ELISA - Chemiluminescent ELISA - Fluorescent ELISA - Electrochemiluminescence immunoassays - Bead-based immunoassays - This report is focused on the use of Quantitative Immunoassay products in life science research market. The following suppliers were surveyed for this report: - Abcam - Affymetrix/eBioscience - BD Biosciences - Bio-Rad - GE Healthcare/Amersham - KPL/SeraCare - Luminex (direct) - Meso Scale Discovery - Perkin Elmer - R&D Systems/Biotechne - Roche Applied Science - Sigma/EMD Millipore - Thermo Fisher Scientific (including Life Technologies, Pierce, Invitrogen, Novex, Molecular Probes) Key Topics Covered: 1. Executive Summary 2. Dashboard "At A Glance" 3. Market Opportunity Matrix 4. Respondent Qualification 5. Demographics 6. Frequency of Performance: Life Science Techniques 7. Frequency of Use: Immunoassay Methods & Additional Protein Related Method 8. Co-Performance: Quantitative Immunoassay Methods & Life Science Techniques 9. Throughput, Growth Rates, Price & Monthly Spend 10. Market Size 11. Percentage of Spend with Suppliers of Immunoassay Products 12. Customer Satisfaction & Interest in Switching 13. Product Feature Influencing Purchase Decisions 14. Primary Focus/Application of Protein Analysis Research & Use of Protein Classes/Categories 15. Desired Changes to Immunoassay Products 16. Appendix I: Supporting Data 17. Appendix II: The Capabilities and Life Science Dashboards TM Available Companies Mentioned - Abcam - Affymetrix/eBioscience - BD Biosciences - Bio-Rad - GE Healthcare/Amersham - KPL/SeraCare - Luminex (direct) - Meso Scale Discovery - Perkin Elmer - R&D Systems/Biotechne - Roche Applied Science - Sigma/EMD Millipore - Thermo Fisher Scientific (including Life Technologies, Pierce, Invitrogen, Novex, Molecular Probes) For more information about this report visit http://www.researchandmarkets.com/research/ds...antitative

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Biotechnology, In Vitro Diagnostics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spotlight on AI-Powered Smart Homes for 2027

Updated Category News Views 6

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 3

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 3

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 6

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
BeyondCPG Accelerator Launches Seventh Growth Program

Updated Category News Views 4

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 5

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 2

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 6

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Alex Jones Returns to Austin: New Studio, New Plans

Updated Category News Views 5

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 2

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading

Top 5 Most Recently Viewed Articles

Phoenix Nest Lands Grant to Advance Gene Therapy

Updated Category News Views 19

Phoenix Nest's New Financial Boost and Its Mission Alright, folks, here’s the scoop. Phoenix Nest, a biotech company that’s as rare as the condition it’s fighting, has just bagged a $2.98 million Small Business Innovation Research (SBIR) grant. This isn’t just pocket change—it’s a lifeline for their mission to battle Sanfilippo Syndrome Type C with a...

Continue Reading
Peoples Bancorp Inc. Announces Attractive Quarterly Dividend

Updated Category News Views 133

Peoples Bancorp Inc. Announces Quarterly Dividend The Board of Directors of Peoples Bancorp Inc. (NASDAQ: PEBO) has officially declared a quarterly cash dividend of $0.41 per common share. This decision reflects the company’s strong financial performance and commitment to returning value to its shareholders. Details of the Dividend Declaration The dividend will be...

Continue Reading
Property Meld's New Acquisition: Transforming Maintenance with AI

Updated Category News Views 517

Property Meld Expands Capabilities with Mezo Acquisition Property Meld, recognized as a leader in the property maintenance operations sector, has made a significant advancement by acquiring Mezo, an innovative artificial intelligence software company. This strategic acquisition reflects Property Meld's ongoing commitment to improving property maintenance through enhanced...

Continue Reading
First Solar Faces Unique Challenges as BofA Adjusts Outlook

Updated Category News Views 75

First Solar's Adjusted Price Target by BofA Securities Recently, BofA Securities updated its perspective on First Solar (NASDAQ: FSLR), lowering the stock's price target from $321 to $269 while maintaining a Buy rating. This adjustment came in the wake of First Solar's report for the third quarter, reaffirming their positive outlook for the company despite the new...

Continue Reading
Exploring Surge in Movie Production Market Through 2028

Updated Category News Views 133

Growth in the Movie Production Market The global movie production market is on a promising trajectory, set to expand by USD 56.11 billion from 2024 to 2028. This growth rate corresponds to a compounded annual growth rate (CAGR) of 10.76%. As entertainment continues to evolve, this market reflects the dynamic changes in consumer preferences and technology. Market...

Continue Reading